Abstract:A quantitative 'H NMR procedure for the determination of bilobalide and ginkgolides A, B, C and J in Ginkgo bilobu leaves and in phytopharmaceuticals without prior chromatographic separation of the mixture has been developed. The method is based on the comparison of the integral of each H-12 proton of the five ginkgo terpene trilactones with that of the olefinic protons of the internal standard (maleic acid). These protons are all well separated at 200 MHz and occur in a less crowded region of the NMR spectrum… Show more
“…Based on earlier 1 H NMR investigations of Ginkgo biloba extracts (van Beek et al 1993; Choi et al 2003; Li et al 2004), spectra of all samples were acquired in acetone- d 6 with an inter-pulse delay of 2.84 s, which assured full relaxation of magnetization between excitations. The spectra constitute the dataset for the multivariate data analysis, and an overview of the spectra is shown in Fig.…”
Commercial preparations of Ginkgo biloba are very complex mixtures prepared from raw leaf extracts by a series of extraction and prepurification steps. The pharmacological activity is attributed to a number of flavonoid glycosides and unique terpene trilactones (TTLs), with largely uncharacterized pharmacological profiles on targets involved in neurological disorders. It is therefore important to complement existing targeted analytical methods for analysis of Ginkgo biloba preparations with alternative technology platforms for their comprehensive and global characterization. In this work, 1H NMR-based metabolomics and hyphenation of high-performance liquid chromatography, photo-diode array detection, mass spectrometry, solid-phase extraction, and nuclear magnetic resonance spectroscopy (HPLC-PDA-MS-SPE-NMR) were used for investigation of 16 commercially available preparations of Ginkgo biloba. The standardized extracts originated from Denmark, Italy, Sweden, and United Kingdom, and the results show that 1H NMR spectra allow simultaneous assessment of the content as well as identity of flavonoid glycosides and TTLs based on a very simple sample-preparation procedure consisting of extraction, evaporation and reconstitution in acetone-d6. Unexpected or unwanted extract constituents were also easily identified in the 1H NMR spectra, which contrasts traditional methods that depend on UV absorption or MS ionizability and usually require availability of reference standards. Automated integration of 1H NMR spectral segments (buckets or bins of 0.02 ppm width) provides relative distribution plots of TTLs based on their H-12 resonances. The present study shows that 1H NMR-based metabolomics is an attractive method for non-selective and comprehensive analysis of Ginkgo extracts.Electronic supplementary materialThe online version of this article (doi:10.1007/s11306-009-0195-x) contains supplementary material, which is available to authorized users.
“…Based on earlier 1 H NMR investigations of Ginkgo biloba extracts (van Beek et al 1993; Choi et al 2003; Li et al 2004), spectra of all samples were acquired in acetone- d 6 with an inter-pulse delay of 2.84 s, which assured full relaxation of magnetization between excitations. The spectra constitute the dataset for the multivariate data analysis, and an overview of the spectra is shown in Fig.…”
Commercial preparations of Ginkgo biloba are very complex mixtures prepared from raw leaf extracts by a series of extraction and prepurification steps. The pharmacological activity is attributed to a number of flavonoid glycosides and unique terpene trilactones (TTLs), with largely uncharacterized pharmacological profiles on targets involved in neurological disorders. It is therefore important to complement existing targeted analytical methods for analysis of Ginkgo biloba preparations with alternative technology platforms for their comprehensive and global characterization. In this work, 1H NMR-based metabolomics and hyphenation of high-performance liquid chromatography, photo-diode array detection, mass spectrometry, solid-phase extraction, and nuclear magnetic resonance spectroscopy (HPLC-PDA-MS-SPE-NMR) were used for investigation of 16 commercially available preparations of Ginkgo biloba. The standardized extracts originated from Denmark, Italy, Sweden, and United Kingdom, and the results show that 1H NMR spectra allow simultaneous assessment of the content as well as identity of flavonoid glycosides and TTLs based on a very simple sample-preparation procedure consisting of extraction, evaporation and reconstitution in acetone-d6. Unexpected or unwanted extract constituents were also easily identified in the 1H NMR spectra, which contrasts traditional methods that depend on UV absorption or MS ionizability and usually require availability of reference standards. Automated integration of 1H NMR spectral segments (buckets or bins of 0.02 ppm width) provides relative distribution plots of TTLs based on their H-12 resonances. The present study shows that 1H NMR-based metabolomics is an attractive method for non-selective and comprehensive analysis of Ginkgo extracts.Electronic supplementary materialThe online version of this article (doi:10.1007/s11306-009-0195-x) contains supplementary material, which is available to authorized users.
“…10 -12 Moreover, totally different approaches, such as biological standardization using the PAF-antagonist properties of ginkgolides 13 and 1 H NMR spectroscopy, 14 have been proposed. Recently, Camponovo et al 15 developed an HPLC method using either thermospray (TSP) MS detection or evaporative light scattering detection (ELSD).…”
“…To standardize commercial ginkgo products and to carry out quality control studies, assays have been reported based on a wide variety of analytical techniques including HPLC or capillary electrophoresis with UV absorbance detection [20,21], HPLC with refractive index detection [22], HPLC with evaporative light scattering detection (ELSD) [23], gas chromatography (GC) with flame ionization detection [24], GC-mass spectrometry (GC-MS) [25], NMR [26], and liquid chromatography-mass spectrometry (LC-MS) [27][28][29][30]. Although ginkgo extracts usually contain considerable quantities of flavonoids which have strong UV absorption, terpenoid lactones lack UV chromophores so that even trace amounts of co-eluting compounds such as the abundant flavonoids might interfere with their detection.…”
Ginkgo biloba (ginkgo) is one of most frequently used botanical dietary supplements. The bioactive constituents include the terpenoid lactones consisting of bilobalide and the ginkgolides A, B, C, and J. A new assay based on high performance liquid chromatography-electrospray tandem mass spectrometry (LC-MS-MS) was developed for the measurement of the terpenoid lactones in ginkgo products such as leaf powder and extracts. Initially, the MS-MS fragmentation pathways of ginkgolides were investigated to identify abundant fragment ions that might be useful for the sensitive and selective detection of ginkgolides and bilobalide during LC-MS-MS. Then, sample preparation and clean-up procedures were streamlined to maximize throughput by taking advantage of the selectivity of LC-MS-MS detection. Analyte recoveries exceeded 90%, the intra-assay and interassay relative standard deviations were less than 5%, the relative error was less than 8%, and the limits of detection and quantification were from 3.6-120 fmol and 11-350 fmol, respectively, depending upon the analyte that was injected onto the HPLC column. Therefore, this LC-MS-MS assay facilitated the rapid quantitative analysis of ginkgolides A, B, C, and J, and bilobalide in ginkgo dietary supplements with excellent recovery, reproducibity, accuracy, and sensitivity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.